Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | Elucidating risk factors in taking epilepsy medication during pregnancy

Kimford Meador, MD, FAAN, Stanford University, Stanford, CA, comments on which children are more at risk of developing adverse effects as a result of mothers taking antiseizure medication. Whilst different drugs such as lamotrigine carry less risk, all medications have a dose-dependent risk and a compromise must be made between safety and efficacy. Dr Meador additionally highlights potential genetic markers that may indicate children who are at higher risk of being affected by epilepsy medication. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.


Research support from the National Institutes of Health and Eisai Inc; the Epilepsy Study Consortium pays Dr. Meador’s university for his research consultant time related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma, and Vivus Pharmaceuticals.